UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012585
Receipt number R000014561
Scientific Title Safety of dietary supplements including n-3 PUFA (Imark S®) for the maintenance of remission in patients with Crohn's disease: A pilot study.
Date of disclosure of the study information 2014/01/10
Last modified on 2015/11/26 11:30:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety of dietary supplements including n-3 PUFA (Imark S®) for the maintenance of remission in patients with Crohn's disease: A pilot study.

Acronym

Safety of dietary supplements including n-3 PUFA for CD.

Scientific Title

Safety of dietary supplements including n-3 PUFA (Imark S®) for the maintenance of remission in patients with Crohn's disease: A pilot study.

Scientific Title:Acronym

Safety of dietary supplements including n-3 PUFA for CD.

Region

Japan


Condition

Condition

Crohn's disease

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety and efficacy of liquid supplements including n-3 PUFA(Nippon Suisan Kaisha Ltd. "Imark S®") for remission patients with Crohn's disease.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Phase I,II


Assessment

Primary outcomes

Safety study (Blood test indicators, inflammatory cytokine, CDAI)

Key secondary outcomes

Safety check depending on the number of intake.(100ml X 1 or 2 bottle)
Efficacy check of maintenance for remission.(Using CDAI score)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

After 3 month intervention with Imark S supplements, to compare the data before ingestion with after each months intervention.
1 month(30 days): 1 bottle of ingestion/ a day
2 month(30 days): No ingestion
3 month(30 days): 2 bottles of ingestion/ a day

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients diagnosed with Crohn's diseases.
2) Patients expected over 3 month-survival from the first day of this study.
3) Patients who can orally ingestion.
4) Patients whose condition are in remission
5) Patients who are obtained with the prior written consent.

Key exclusion criteria

1) Patients with the following diseases.
(cirrhosis, chronic renal failure, diabetes with insulin therapy and so on)
2) Patients with steroid treatment
3) Patients with anti-TNF agents treatment
4) Patients with food allergy
5) Patients less than 20 years old.
6) Patients with xerosis cutis and impossible to measure body composition
7) Patients judged to be inappropriate for this study from the doctor in charge.

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshinori Ito

Organization

Osaka University Graduate School of Medicine

Division name

Department of Complementary and Alternative Medicine

Zip code


Address

2-2 Yamadaoka, Suita, Osaka, Japan

TEL

06-6879-3498

Email

juki@cam.med.osaka-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Asuka Yasueda

Organization

Osaka University Graduate School of Medicine

Division name

Department of Complementary and Alternative Medicine

Zip code


Address

2-2 Yamadaoka, Suita, Osaka, Japan

TEL

06-6879-3498

Homepage URL


Email

a-yasueda@cam.med.osaka-u.ac.jp


Sponsor or person

Institute

Osaka University Graduate School Department of Complementary and Alternative Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Osaka University Graduate School Department of Gastroenterology

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2014 Year 01 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 12 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 01 Month 10 Day

Last follow-up date

2014 Year 10 Month 31 Day

Date of closure to data entry

2014 Year 11 Month 30 Day

Date trial data considered complete

2015 Year 01 Month 10 Day

Date analysis concluded

2015 Year 03 Month 10 Day


Other

Other related information



Management information

Registered date

2013 Year 12 Month 16 Day

Last modified on

2015 Year 11 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014561


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name